logo
Plus   Neg
Share
Email

Medtronic Plc Q4 Profit Beats Estimates - Quick Facts

Medtronic plc (MDT) said its fourth-quarter non-GAAP net income and non-GAAP diluted EPS were up 7 percent and 8 percent, respectively, from previous year. Adjusting for negative impact from foreign currency, fourth-quarter non-GAAP diluted EPS increased 9 percent. Revenue grew 3.6% organic, for the quarter. Looking forward, for fiscal 2020, Medtronic projects revenue growth to approximate 4.0 percent on an organic basis.

For the fourth-quarter, non-GAAP earnings per share was $1.54 compared to $1.42 previous year. On average, 25 analysts polled by Thomson Reuters expected the company to report profit per share of $1.47 for the quarter. Analysts' estimates typically exclude special items.

Fourth-quarter revenue was $8.1 billion, flat as reported. Analysts expected revenue of $8.11 billion, for the quarter.

For fiscal 2020, the company expects non-GAAP EPS in the range of $5.44 to $5.50, including an estimated 10 cent negative impact from foreign exchange based on current rates. Analysts expect the company to report profit per share of $5.44.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The National Aeronautics and Space Administration or NASA extended its contract with Boeing to build the rocket core stages for its Space Launch System or SLS beyond the first two Artemis missions, and through the next decade. Boeing is the current lead contractor for the core stages of the rockets for the first two missions. The new contract includes the production of ten SLS core stages. The U.S. Food and Drug Administration approved an all-time record total of 1,171 generic drugs in fiscal 2019, breaking its previous record of 971 approvals in fiscal 2018. This year's approvals include 935 full approvals and 236 tentative approvals. A generic drug is a pharmaceutical drug that contains the same chemical substance and performs the same functions as a branded drug. Air Canada has extended its grounding of Boeing's 737 MAX-8 aircraft and removed it from its flying schedule until February 14, 2020. The airline had earlier said its fleet of 24 grounded jetliners will not join its schedules until January 8, 2020. The Canadian flag carrier said the extension is a result of the ongoing regulatory uncertainty about the timing of the aircraft returning to service.
Follow RTT
>